Issues in making a therapeutic choice: recombinant and/or human-derived products.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 89, doi. 10.1046/j.1365-2516.2001.00415.x
- Publication type:
- Article
Works matching IS 13518216 AND DT 2001 AND VI 7 AND IP 1
Results: 26
1
2
Myelodysplastic features in patients with long-term HIV infection and haemophilia.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 47, doi. 10.1046/j.1365-2516.2001.00445.x
- By:
- Publication type:
- Article
3
Determination of haemophilia A carrier status by mutation analysis.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 20, doi. 10.1046/j.1365-2516.2001.00453.x
- By:
- Publication type:
- Article
4
Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 9, doi. 10.1046/j.1365-2516.2001.00455.x
- By:
- Publication type:
- Article
5
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 26
- By:
- Publication type:
- Article
6
The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 82
- By:
- Publication type:
- Article
7
Developing theory-based risk-reduction interventions for HIV-positive young people with haemophilia.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 64
- By:
- Publication type:
- Article
8
Safer sex decision-making among men with haemophilia and HIV and their female partners.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 72
- By:
- Publication type:
- Article
9
Distinct advantages of high temperature dry-heated plasma-derived factor VIII concentrate.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 131, doi. 10.1046/j.1365-2516.2001.0460a.x
- By:
- Publication type:
- Article
10
Erratum.
- Published in:
- 2001
- Publication type:
- Erratum
11
Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 33, doi. 10.1046/j.1365-2516.2001.00461.x
- By:
- Publication type:
- Article
12
An emerging role for interferon in haemophiliacs with chronic hepatitis C?
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 6, doi. 10.1046/j.1365-2516.2001.00462.x
- By:
- Publication type:
- Article
13
Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 13
- By:
- Publication type:
- Article
14
Product choice and haemophilia treatment in the Netherlands.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 96, doi. 10.1046/j.1365-2516.2001.00464.x
- By:
- Publication type:
- Article
15
Immune tolerance induction: recombinant vs. human-derived product.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 109, doi. 10.1046/j.1365-2516.2001.00466.x
- By:
- Publication type:
- Article
16
Are recombinant products really infection risk free?
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 114, doi. 10.1046/j.1365-2516.2001.00467.x
- By:
- Publication type:
- Article
17
Choice of factor concentrates for haemophilia: a developing world perspective.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 117, doi. 10.1046/j.1365-2516.2001.00468.x
- By:
- Publication type:
- Article
18
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 99, doi. 10.1046/j.1365-2516.2001.00471.x
- By:
- Publication type:
- Article
19
The responsibility of separating truth from myth to patient and family.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 91, doi. 10.1046/j.1365-2516.2001.00472.x
- By:
- Publication type:
- Article
20
Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 103, doi. 10.1046/j.1365-2516.2001.00473.x
- By:
- Publication type:
- Article
21
Regulatory perspective on making a therapeutic choice for anti-haemophilic factors.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 123, doi. 10.1046/j.1365-2516.2001.00474.x
- By:
- Publication type:
- Article
22
Rapidly destructive arthropathy of the hip in haemophilia.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 127, doi. 10.1046/j.1365-2516.2001.00475.x
- By:
- Publication type:
- Article
23
Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 53, doi. 10.1046/j.1365-2516.2001.00476.x
- By:
- Publication type:
- Article
24
Viral markers and use of factor products among Finnish patients with bleeding disorders.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 42, doi. 10.1046/j.1365-2516.2001.00477.x
- By:
- Publication type:
- Article
25
A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 39, doi. 10.1046/j.1365-2516.2001.00478.x
- By:
- Publication type:
- Article
26
Methods to treat chronic haemophilic synovitis.
- Published in:
- Haemophilia, 2001, v. 7, n. 1, p. 1, doi. 10.1046/j.1365-2516.2001.00481.x
- By:
- Publication type:
- Article